Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk.

Breast cancer research and treatment - 1 Oct 2008

Talbott Kathryn E, Gammon Marilie D, Kibriya Muhammad G, Chen Yu, Teitelbaum Susan L, Long Chang-Min, Gurvich Irina, Santella Regina M, Ahsan Habibul

Abstract excerpt

Due to the established association between estrogen levels and breast cancer risk, polymorphic variation in genes regulating estrogen levels is thought to be related to breast cancer risk. Aromatase, the protein product of the CYP19 gene, is involved in the production of endogenous estrogens via androgen conversion. We examined whether polymorphic variation in CYP19 associated with increased breast cancer risk in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aromatase
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Gene Frequency

Share to Haplotypes

Share to Odds Ratio

Share to Premenopause

Share to Risk Assessment

Source

Identifiers

PMID: 17975727
DOI: 10.1007/s10549-007-9794-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk.PMID 17975727Read ↗

Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjects.Semantic proximity Read ↗

Elevated Aromatase (CYP19A1) Expression Is Associated with a Poor Survival of Patients with Estrogen Receptor Positive Breast Cancer.Semantic proximity Read ↗

Effect of CYP19 rs6493497 and rs7176005 haplotype status on in vivo aromatase transcription, plasma and tissue estrogen levels in postmenopausal women.Semantic proximity Read ↗

Analysis of the rs10046 polymorphism of aromatase (CYP19) in premenopausal onset of human breast cancer.Semantic proximity Read ↗

Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors.Semantic proximity Read ↗

Association between gynecomastia and aromatase (CYP19) polymorphisms.Semantic proximity Read ↗

Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk.Semantic proximity Read ↗

Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women.Semantic proximity Read ↗

Human aromatase: gene resequencing and functional genomics.Semantic proximity Read ↗

Significance of the Estrogen Hormone and Single Nucleotide Polymorphisms in the Progression of Breast Cancer among Female.Semantic proximity Read ↗

CYP3A variation, premenopausal estrone levels, and breast cancer risk.Semantic proximity Read ↗

A rare CYP19 (aromatase) variant may increase the risk of breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.